Figure 3. Association Between Rivaroxaban and Venous Thromboembolism .
Shown are the cumulative incidence curves for venous thromboembolism in patients assigned to rivaroxaban vs placebo and the hazard ratio (HR) and associated 95% CI.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.